Age Factors < Aged < Aged, 80 and over

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 60.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000023 (2012)		Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
000058 (2009)		Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study.
000060 (2009)		Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors.
000075 (2008)		Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy.
000076 (2008)		Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors.
000084 (2007)		Pathology underrates colon cancer extranodal and nodal metastases; ex vivo radioimmunodetection helps staging.
000094 (2006)		Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
000102 (2006)		Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis.
000110 (2005)		Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
000125 (2004)		Diagnostic management of suspected metastatic thyroid carcinoma: clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine scans.
000129 (2003)		Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial.
000130 (2003)		Octreotide imaging plus bone scintigrams to optimally localize gastroenteropancreatic neuroendocrine tumors.
000132 (2003)		Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects.
000134 (2003)		Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck.
000135 (2002)		[Scintigraphy by l'Octreoscan in the management of head and neck paragangliomas].
000146 (2001)		Is the thrombopoietin assay useful for differential diagnosis of thrombocytopenia? Analysis of a cohort of 160 patients with thrombocytopenia and defined platelet life span.
000147 (2001)		Indium-111 octreotide scintigraphy of Merkel cell carcinomas and their metastases.
000154 (2000)		Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography.
000163 (1999)		Somatostatin receptor scintigraphy in pituitary adenomas: a somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivo.
000165 (1999)		In-111 pentetreotide scintigraphy to monitor nonsecreting neuroendocrine tumors.
000168 (1999)		Factor analysis of dynamic series (FADS) in somatostatin receptor imaging.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i -k "Aged" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i  \
                -Sk "Aged" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Aged
}}

---

This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024